What is the dosing regimen for Advair (fluticasone-salmeterol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Advair should be taken twice daily, with a dose that depends on the level of severity or control of asthma or COPD, with the most common starting dose for adults being 250/50 (250 mcg fluticasasteroid and 50 mcg salmeterol) inhaled twice daily. The medication comes in three strengths: 100/50,250/50, and as indicated in the study from the Journal of Allergy and Clinical Immunology 1.

Key Considerations

  • The dose may be adjusted based on symptom control, with a maximum of two inhalations twice daily.
  • It is essential to rinse the mouth with water after each use to prevent thrush.
  • The medication should be used in conjunction with an inhaled corticosteroid, as indicated by the study in the European Respir 1.

Potential Adverse Effects

  • Tachycardia, skeletal muscle tremor, hypokalemia, and decreased duration of protection against exercise-induced bronchospasm may occur with regular use, as noted in the study 1.
  • A diminished bronchoprotective effect may occur within a week of chronic therapy, and there is a potential risk of uncommon severe life-threatening or fatal exacerbation, as discussed in the study 1.

Important Considerations for Use

  • The medication should not be used for acute symptom relief or exacerbations, and it should only be used with inhaled corticosteroids, as indicated by the study 1.
  • The dose for children 5-12 years of age is based on clinical trials using a dry powder inhaler with slightly different delivery characteristics, as noted in the study 1.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION • For oral inhalation only. (2) • Treatment of Asthma in Patients Aged 12 Years and Older: 1 inhalation of fluticasone propionate and salmeterol inhalation powder 100 mcg/50 mcg, fluticasone propionate and salmeterol inhalation powder 250 mcg/50 mcg, or fluticasone propionate and salmeterol inhalation powder 500 mcg/50 mcg twice daily. Starting dosage is based on asthma severity. (2.1) • Treatment of Asthma in Patients Aged 4 to 11 Years: 1 inhalation of fluticasone propionate and salmeterol inhalation powder 100 mcg/50 mcg twice daily. (2.1) • Maintenance Treatment of COPD: 1 inhalation of fluticasone propionate and salmeterol inhalation powder 250 mcg/50 mcg twice daily. (2.2)

The dosing regimen for Advair (fluticasone-salmeterol) is as follows:

  • Asthma in patients 12 years and older: 1 inhalation of 100 mcg/50 mcg, 250 mcg/50 mcg, or 500 mcg/50 mcg twice daily, based on asthma severity.
  • Asthma in patients 4 to 11 years: 1 inhalation of 100 mcg/50 mcg twice daily.
  • Maintenance treatment of COPD: 1 inhalation of 250 mcg/50 mcg twice daily. 2

From the Research

Dosing Regimen for Advair (fluticasone-salmeterol)

  • The dosing regimen for Advair (fluticasone-salmeterol) varies depending on the patient's condition and age 3, 4, 5, 6, 7.
  • For adults with chronic obstructive pulmonary disease (COPD), the recommended dose is twice-daily salmeterol/fluticasone propionate 50/250 microg 3.
  • For patients with moderate-to-severe COPD, twice-daily inhaled salmeterol/fluticasone propionate 50/250 or 50/500 microg can be used 3.
  • In patients with asthma, the Advair Diskus is available in 3 strengths of fluticasone propionate (100,250, and 500 microg) and a fixed dose (50 microg) of salmeterol, administered twice daily 4, 5.
  • A study also investigated the efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily, which may be a valuable treatment option for some patients 7.
  • The combination of salmeterol 50 microg and fluticasone 250 microg in a single dry powder inhaler was found to be superior to twice the dose of fluticasone propionate (500 microg) for the treatment of symptomatic moderate asthma 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.